(Q39350862)

11 September 2017

title

N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese (English)

1 reference

11 September 2017

Y Zhong

1

1 reference

11 September 2017

Y Wu

2

1 reference

11 September 2017

C Li

3

1 reference

11 September 2017

J Tang

4

1 reference

11 September 2017

X Wang

5

1 reference

11 September 2017

G Ren

6

1 reference

11 September 2017

A Carr

7

1 reference

11 September 2017

R Pérez

8

1 reference

11 September 2017

W Guo

9

1 reference

11 September 2017

publication date

10 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

18

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

741-747

1 reference

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Establishment and characterization of an oral melanoma cell line (ME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

N-Glycolylneuraminic acid in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Oral malignant melanoma: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

21 January 2018

Primary mucosal melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01939.X

10.1111/J.1601-0825.2012.01939.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference